Dublin, June 28, 2017 -- Research and Markets has announced the addition of the "Global Neurosurgical Products Market: Drivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering.
The Global Neurosurgical Devices Market is estimated to witness a CAGR of 10.5% during the forecast period 2017-2023.
The regions covered in the report are the Americas, EMEA, and Asia Pacific (APAC). The Americas is set to be the leading region for the neurosurgical devices market growth followed by EMEA. There has been a significant increase in the number of individuals undergoing treatment for various neurosurgical procedures in the US. For instance, according to the American Academy of Neurology, neurological disorders accounted for 7% of all global diseases in 2014.
Europe accounted for the second largest market with chronic pain being one of the major complications with rising burden of cerebral disorders cases. In 2015, the public spending on healthcare in Europe amounted to 18% of the overall government expenditure. The expenditure on chronic pain care with neurostimulation devices is directly reimbursed to hospitals within the NHS. Clinical evidence of neurosurgical devices, when compared to other treatment such as drug therapy, is expected to increase during the forecast period.
The APAC neurosurgical devices market revenue is expected to reach $2.4 billion by 2023, growing at a CAGR of 13% during the forecast period 2016-2023. The factors such as high prevalence of neurological diseases, presence of a large pool of patients, increase in disposable income, and rise in awareness about treatment for complex neurosurgeries are owing to a substantial growth in the market. Also, the increase in government spending in healthcare, infrastructure, research centers, and the establishment of manufacturing facilities by major vendors are influencing high growth in the market.
Key Players: Boston Scientific Corp., DePuy Synthes, Inc., Integra LifeSciences Holdings Corp., Medtronic PLC, Stryker Corp., and other predominate & niche players.
Key Topics Covered:
1. Report Outline
2. Executive Summary
3. Market Positioning
3.1 Total Addressable Market (TAM): Neurosurgical Industry
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
4. Market Outlook
5. Market Characteristics
5.1 Ecosystem
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.2 Restraints
5.3.3 Opportunities
5.3.4 DRO - Impact Analysis
6. Neurosurgical Market by Application: Market Size and Analysis
6.1 Overview
6.2 Neurostimulation devices
6.3 Interventional neurology device
6.4 Cerebrospinal fluid devices
6.5 Neurosurgery devices
6.6 Neurosurgical navigation systems
7. Neurosurgical Market by Regions: Market Size and Analysis
8. Vendor Profiles
8.1 Boston Scientific Corp.
8.2 DePuy Synthes Inc. (a subsidiary of Johnson & Johnson)
8.3 Medtronic PLC
8.4 Stryker Corp.
8.5 Integra LifeSciences Corp.
9. Companies to Watch For
9.1 MicroVention Inc.
9.2 Penumbra Inc.
9.3 Cyberonics Inc
10. Competitive Landscape
10.1 Competitor Product & Geography Benchmarking
10.2 Market Landscape
11 What Our Peers Are Estimating
For more information about this report visit https://www.researchandmarkets.com/research/wk8dks/global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Neurology Devices , Surgical Devices


Apple Turns 50: From Garage Startup to AI Crossroads
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 



